Redcare Pharmacy: continued very fast growth combined with major margin lift; adj. EBITDA 3.2% in Q3, vs. 0.4% last year.

Redcare Pharmacy NV published this content on October 31, 2023, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 15, 2025 at 08:18 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io